Drug Type Fusion protein |
Synonyms MWN 103, MWN103 |
Mechanism FGF21R agonists, GCGR agonists(Glucagon receptor agonists), GIPR agonists(Gastric inhibitory polypeptide receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | CN | - | |
Nonalcoholic Steatohepatitis | Phase 1 | CN | - | |
Obesity | Phase 1 | CN | - | |
Sleep Apnea, Obstructive | Preclinical | CN | 18 Apr 2024 |